NITAG Support Survey Form
Please complete this survey as a NITAG (minimum of Chair or Secretariat plus 1 other member). It aims to understand your future VPOP support needs and it is essential that we are able to contact you. By completing it, you consent to the use of the collected data for these purposes. Thank you for your participation. Targeted country NITAGs: Benin, Burkina Faso, Senegal, Ghana, Sierra Leone, Côte d’Ivoire, Mali, Liberia, Tanzania, Kenya, Uganda, South Africa, Lesotho, Malawi, Zambia, Zimbabwe, Chad, Madagascar, Cameroon.
1. Country
*
a. If you have completed this form before, which one of your NITAG members (email) have done so?
b. What NITAG members are completing this form now (name/emails)
*
c. Please provide the email of your NITAG chair or secretariat for follow-up.
*
Back
Next
Save
2. There is at least 50% of staff time dedicated to both administrative and technical duties directly supporting the NITAG.
*
Yes
No
3. When developing recommendations, to what extent does your NITAG use local evidence (e.g., epidemiological data, cost-effectiveness studies, WHO guidance)?
*
Consistently
Sometimes
Never
4.Does your NITAG collaborate with universities or research institutions to access or generate evidence?
*
Always
Sometimes
Never
5.What are the main challenges your NITAG faces in making evidence-based recommendations or optimising vaccine use? (example - the lack of local data...)
*
0/250
6. To what extent have NITAG recommendations been adopted by the Ministry of Health in the past 2 years?
*
Most recommendations
Some recommendations
None
7. Has your NITAG previously applied structured tools/frameworks (e.g., EtR) for decision-making?
*
Yes, frequently
Yes, occasionally
Not at all
8. Name the vaccines your NITAG plans on introducing / prioritizing in the next 3-5 years.
*
0/200
9.What are the vaccines your NITAG plans on switching / optimizing?
*
0/200
10.What kind of technical support would help strengthen your NITAG’s vaccine decision-making processes?
*
Access to training in evidence-informed decision-making (EIDM) and vaccinology
Support in conducting evidence reviews (e.g., rapid reviews, systematic reviews)
Improved access to local epidemiological and cost-effectiveness data
Technical assistance in applying prioritization and optimization frameworks (e.g., NVI-PST, NMAT)
Other
11.What is your NITAG mostly hoping to learn / or have learned through this webinar series? (comment below if learned or hoped to learn)
*
Better understanding and application of the NVI-PST tool
Strengthening evidence use in prioritization and optimization decisions
Practical approaches for implementing vaccine switches or new introductions
Assistance technique pour l’application des cadres de priorisation et d’optimisation (ex. : NVI-PST, NMAT)
Other
You may comment here on any aspects about expectations versus what was learned.
Save
Submit
Should be Empty: